Groowe Groowe / Newsroom / LRMR
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LRMR News

Larimar Therapeutics, Inc. Common Stock

Form 8-K

sec.gov
LRMR

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March

globenewswire.com
LRMR

Larimar Therapeutics to Participate in Upcoming Investor Conferences in March

globenewswire.com
LRMR

Form 8-K

sec.gov
LRMR

Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

globenewswire.com
LRMR

Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering

globenewswire.com
LRMR

Biotech and Big Tech Drive the Morning Narrative

globenewswire.com
VIR LRMR META AMD

Form 8-K

sec.gov
LRMR

Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026

globenewswire.com
LRMR

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

globenewswire.com
LRMR